Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01477320 · ClinicalTrials.gov registry record · NA

Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.

A NA study of Clostridium Difficile Colitis and Gastrointestinal Hemorrhage, sponsored by Mohamed Saad.

Completed
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT01477320 is a NA study of Clostridium Difficile Colitis and Gastrointestinal Hemorrhage that has completed, run by Mohamed Saad. The registered enrollment target is 124 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01477320, a NA study of Clostridium Difficile Colitis and Gastrointestinal Hemorrhage, has completed, sponsored by Mohamed Saad.

COMPLETED
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

study is to determine if proton pump inhibitors plus enteral nutrition is superior to enteral nutrition alone as a stress ulcer prophylaxis strategy in critically ill patients in terms of incidence of overt and significant GI bleeding related to stress gastropathy.

Interventions

  • DRUG Pantoprazole 40 mg IV daily and tube feed.
  • OTHER Placebo and tube feed

Study Locations (1)

Kentucky

  • University of Louisville hospital - Louisville

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2013-09
Est. Completion 2016-07
Phase NA

Sponsor

Mohamed Saad

1 total trials

What the Registry Record Tells You About NCT01477320

The ClinicalTrials.gov registry entry for NCT01477320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mohamed Saad, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Clostridium Difficile Colitis appearing as the primary indexed condition, and to 2 interventions - of which Pantoprazole 40 mg IV daily and tube feed. is the first listed.

NCT01477320 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT01477320 about?

NCT01477320 is a clinical study titled "Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.". study is to determine if proton pump inhibitors plus enteral nutrition is superior to enteral nutrition alone as a stress ulcer prophylaxis strategy in critically ill patients in terms of incidence of overt and significant GI bleeding related to stress gastropathy.

What is the current status of trial NCT01477320?

This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2013-09. Estimated completion is 2016-07.

What conditions does trial NCT01477320 study?

This clinical trial studies the following conditions: Clostridium Difficile Colitis, Gastrointestinal Hemorrhage.

What interventions are being tested in trial NCT01477320?

The interventions under investigation include: Pantoprazole 40 mg IV daily and tube feed. (DRUG), Placebo and tube feed (OTHER).

Who is sponsoring clinical trial NCT01477320?

This trial is sponsored by Mohamed Saad, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01477320 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Clostridium Difficile Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.